Do androgens play any role in the physical frailty of ageing men?

International Journal of Andrology

Volumn 34, Issue 3, 2011, Pages 195-211

  O'Connell, M D L ^a   Tajar, A ^a   Roberts, S A ^a   Wu, F C W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Ageing; Androgens; Frailty; Muscle; Sex hormones; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANOLONE; FINASTERIDE; RECOMBINANT CHORIONIC GONADOTROPIN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

AGING; ANDROGEN THERAPY; BODY COMPOSITION; BODY MASS; FRAIL ELDERLY; HORMONE ACTION; HUMAN; MUSCLE ATROPHY; MUSCLE STRENGTH; PRIORITY JOURNAL; REVIEW;

AGED; AGED, 80 AND OVER; AGING; ANDROGENS; FRAIL ELDERLY; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MUSCLE STRENGTH; SARCOPENIA; TESTOSTERONE;

EID: 79955604878     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2010.01093.x     Document Type: Review

References (104)

1. Araujo AB, Travison TG, Bhasin S, Esche GR, Williams RE, Clark RV and McKinlay JB. (2008) Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. J Am Geriatr Soc 56, 2000-2008.
2. Bain J. (2010) Testosterone and the aging male: to treat or not to treat? Maturitas 66, 16-22.
3. Bandeen-Roche K, Xue Q-L, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL and Fried LP. (2006) Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci 61, 262-266.
4. Barzilay JI, Blaum C, Moore T, Li Xue Q, Hirsch CH, Walston JD and Fried LP. (2007) Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 167, 635-641.
5. Baumgartner RN, Waters DL, Gallagher D, Morley JE and Garry PJ. (1999) Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 107, 123-136.
6. Bean JF, Kiely DK, Herman S, Leveille SG, Mizer K, Frontera WR and Fielding RA. (2002) The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc 50, 461-467.
7. van den Beld AW, Huhtaniemi IT, Pettersson KSL, Pols HAP, Grobbee DE, de Jong FH and Lamberts SWJ. (1999) Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab 84, 1334-1339.
8. van den Beld AW, de Jong FH, Grobbee DE, Pols HAP and Lamberts SWJ. (2000) Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85, 3276-3282.
9. Bhasin S, Taylor WE, Singh R, Artaza J, Sinha-Hikim I, Jasuja R, Choi H and Gonzalez-Cadavid NF. (2003) The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol A Biol Sci Med Sci 58, M1103-M1110.
10. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M et al. (2005) Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90, 678-688.
11. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE et al. (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288, 2282-2292.
12. Ble A, Cherubini A, Volpato S, Bartali B, Walston JD, Windham BG, Bandinelli S, Lauretani F, Guralnik JM and Ferrucci L. (2006) Lower plasma vitamin E levels are associated with the frailty syndrome: the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 61, 278-283.
13. Borst SE, Conover CF, Carter CS, Gregory CM, Marzetti E, Leeuwenburgh C, Vandenborne K and Wronski TJ. (2007) Anabolic effects of testosterone are preserved during inhibition of 5α-reductase. Am J Physiol Endocrinol Metab 293, E507-E514.
14. Bortz WM II. (2002) A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci 57, M283-M288.
15. Boxer RS, Dauser DA, Walsh SJ, Hager WD and Kenny AM. (2008) The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 56, 454-461.
16. Breuer B, Trungold S, Martucci C, Wallenstein S, Likourezos A, Libow LS and Zumoff B. (2001) Relationships of sex hormone levels to dependence in activities of daily living in the frail elderly. Maturitas 39, 147-159.
17. Brill KT, Weltman AL, Gentili A, Patrie JT, Fryburg DA, Hanks JB, Urban RJ and Veldhuis JD. (2002) Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab 87, 5649-5657.
18. Buchner DM, Larson EB, Wagner EH, Koepsell TD and De Lateur BJ. (1996) Evidence for a non-linear relationship between leg strength and gait speed. Age Ageing 25, 386-391.
19. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL and Bhasin S. (2005) Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60, 1451-1457.
20. Cawthon PM, Marshall LM, Michael Y, Dam T-T, Ensrud KE, Barrett-Connor E and Orwoll ES. (2007) Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 55, 1216-1223.
21. Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam T-TL, Barrett-Connor E et al. (2009) Sex hormones and frailty in older men: the Osteoporotic Fractures in Men (MrOS) Study. J Clin Endocrinol Metab 94, 3806-3815.
22. Chandler JM, Duncan PW, Kochersberger G and Studenski S. (1998) Is lower extremity strength gain associated with improvement in physical performance and disability in frail, community-dwelling elders? Arch Phys Med Rehabil 79, 24-30.
23. Chaves PHM, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM and Fried LP. (2005) Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the women's health and aging studies i and ii. J Gerontol A Biol Sci Med Sci 60, 729-735.
24. Cigolle CT, Ofstedal MB, Tian Z and Blaum CS. (2009) Comparing models of frailty: the Health and Retirement Study. J Am Geriatr Soc 57, 830-839.
25. Clague JE, Wu FCW and Horan MA. (1999) Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men. Int J Androl 22, 261-265.
26. Clark BC and Manini TM. (2008) Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci 63, 829-834.
27. Corrales JJ, Almeida M, Burgo R, Mories MT, Miralles JM and Orfao A. (2006) Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J Endocrinol 189, 595-604.
28. Emmelot-Vonk MH, Verhaar HJJ, Nakhai Pour HR, Aleman A, Lock TMTW, Bosch JLHR, Grobbee DE and van der Schouw YT. (2008) Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 299, 39-52.
29. Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL et al. for the Study of Osteoporotic Research Fractures Group. (2008) Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 168, 382-389.
30. Fantin F, Francesco VD, Fontana G, Zivelonghi A, Bissoli L, Zoico E, Rossi A, Micciolo R, Bosello O and Zamboni M. (2007) Longitudinal body composition changes in old men and women: interrelationships with worsening disability. J Gerontol A Biol Sci Med Sci 62, 1375-1381.
31. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ and McKinlay JB. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87, 589-598.
32. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR and Urban RJ. (2002) Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282, E601-E607.
33. Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR and Urban RJ. (2003) Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab 88, 358-362.
34. Foldvari M, Clark M, Laviolette LC, Bernstein MA, Kaliton D, Castaneda C, Pu CT, Hausdorff JM, Fielding RA and Singh MAF. (2000) Association of muscle power with functional status in community-dwelling elderly women. J Gerontol A Biol Sci Med Sci 55, M192-M199.
35. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al. (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56, M146-M157.
36. Fried LP, Ferrucci L, Darer J, Williamson JD and Anderson G. (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59, M255-M263.
37. Fugate Woods N, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A and Newman AB. (2005) Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 53, 1321-1330.
38. Giannoulis MG, Sonksen PH, Umpleby M, Breen L, Pentecost C, Whyte M, McMillan CV, Bradley C and Martin FC. (2006) The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab 91, 477-484.
39. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV et al. (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 61, 1059-1064.
40. Gooren L. (2007) Frailty and its relationship to late onset hypogonadism. J Mens Health Gend 4, 466-473.
41. Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ and Montori VM. (2007) Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82, 29-39.
42. Harman SM, Metter EJ, Tobin JD, Pearson J and Blackman MR. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86, 724-731.
43. Hubbard RE, O'Mahony SM, Savva GM, Calver BL and Woodhouse KW. (2009) Inflammation and frailty measures in older people. J Cell Mol Med 13, 3103-3109.
44. Iannuzzi-Sucich M, Prestwood KM and Kenny AM. (2002) Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 57, M772-M777.
45. Kenny AM, Prestwood KM, Gruman CA, Marcello KM and Raisz LG. (2001) Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 56, M266-M272.
46. Khosla S, Atkinson EJ, Dunstan CR and O'Fallon WM. (2002) Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab 87, 1550-1554.
47. Kryger AI and Andersen JL. (2007) Resistance training in the oldest old: consequences for muscle strength, fiber types, fiber size, and MHC isoforms. Scand J Med Sci Sports 17, 422-430.
48. Kwon IS, Oldaker S, Schrager M, Talbot LA, Fozard JL and Metter EJ. (2001) Relationship between muscle strength and the time taken to complete a standardized walk-turn-walk test. J Gerontol A Biol Sci Med Sci 56, B398-B404.
49. Leng SX, Yang HH and Walston JD. (2004) Decreased cell proliferation and altered cytokine production in frail older adults. Aging Clin Exp Res 16, 249-252.
50. Leng SX, Xue Q-L, Tian J, Walston JD and Fried LP. (2007) Inflammation and frailty in older women. J Am Geriatr Soc 55, 864-871.
51. Liu PY, Wishart SM and Handelsman DJ. (2002) A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab 87, 3125-3135.
52. Ly LP and Handelsman DJ. (2002) Muscle strength and ageing: methodological aspects of isokinetic dynamometry and androgen administration. Clin Exp Pharmacol Physiol 29, 39-47.
53. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ and Handelsman DJ. (2001) A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86, 4078-4088.
54. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS and Jones TH. (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 89, 3313-3318.
55. Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, Veldhuis JD and Urban RJ. (1998) Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 83, 1886-1892.
56. Mohr BA, Bhasin S, Kupelian V, Araujo AB, O'Donnell AB and McKinlay JB. (2007) Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc 55, 548-555.
57. Morley J, Perry HR, Kaiser F, Kraenzle D, Jensen J, Houston K, Mattammal M and Perry HJ. (1993) Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41, 149-152.
58. Narici MV, Maffulli N and Maganaris CN. (2008) Ageing of human muscles and tendons. Disabil Rehabil 30, 1548-1554.
59. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL et al. (2006) Dhea in elderly women and dhea or testosterone in elderly men. N Engl J Med, 355, 1647-1659.
60. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ et al. (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Eur Urol 48, 1-4.
61. O'Donnell AB, Travison TG, Harris SS, Tenover JL and McKinlay JB. (2006) Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 91, 425-431.
62. Orwoll E, Lambert LC, Marshall LM, Blank J, Barrett-Connor E, Cauley J, Ensrud K and Cummings SR for the Osteoporotic Fractures in Men Study Group. (2006) Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 166, 2124-2131.
63. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ and Tenover JL. (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90, 1502-1510.
64. Perry HM, Miller DK, Patrick P and Morley JE. (2000) Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. Metabolism 49, 1085-1091.
65. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. (2006) World Population Prospects: The 2006 Revision and World Urbanization Prospects: The 2005 Revision. Available at: Accessed 4 February 2010.
66. Puts MTE, Lips P and Deeg DJH. (2005a) Static and dynamic measures of frailty predicted decline in performance-based and self-reported physical functioning. J Clin Epidemiol 58, 1188-1198.
67. Puts MTE, Visser M, Twisk JWR, Deeg DJH and Lips P. (2005b) Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol 63, 403-411.
68. Rantanen TP, Guralnik JMMDP, Izmirlian GP, Williamson JDMD, Simonsick EMP, Ferrucci LMDP and Fried LPMDMPH. (1998) Association of muscle strength with maximum walking speed in disabled older women. Am J Phys Med Rehabil 77, 299-305.
69. Ravaglia G, Forti P, Lucicesare A, Pisacane N, Rietti E and Patterson C. (2008) Development of an easy prognostic score for frailty outcomes in the aged. Age Ageing 37, 161-166.
70. Reeves ND, Narici MV and Maganaris CN. (2006) Myotendinous plasticity to ageing and resistance exercise in humans. Exp Physiol 91, 483-498.
71. Rockwood K. (2005) What would make a definition of frailty successful? Age Ageing 34, 432-434.
72. Rockwood K and Hubbard R. (2004) Frailty and the geriatrician. Age Ageing 33, 429-430.
73. Rockwood K and Mitnitski A. (2007) Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 62, 722-727.
74. Rockwood K, Abeysundera MJ and Mitnitski A. (2007a) How should we grade frailty in nursing home patients? J Am Med Dir Assoc 8, 595-603.
75. Rockwood K, Andrew M and Mitnitski A. (2007b) A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci 62, 738-743.
76. Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M and Metter EJ. (2002) Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 283, E284-E294.
77. Runnels ED, Bemben DA, Anderson MA and Bemben MG. (2005) Influence of age on isometric, isotonic, and isokinetic force production characteristics in men. J Geriatr Phys Ther 28, 74-84.
78. Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S et al. (2009) Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab 94, 1991-2001.
79. Schaap LA, Pluijm SMF, Smit JH, van Schoor NM, Visser M, Gooren LJG and Lips P. (2005) The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol 63, 152-160.
80. Schaap LA, Pluijm SMF, Deeg DJH, Penninx BW, Nicklas BJ, Lips P et al. (2008) Low testosterone levels and decline in physical performance and muscle strength in older men: findings from two prospective cohort studies. Clin Endocrinol 68, 42-50.
81. Schroeder ET, Terk M and Sattler FR. (2003) Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies. Am J Physiol Endocrinol Metab 285, E16-E24.
82. Semba RD, Bartali B, Zhou J, Blaum C, Ko C-W and Fried LP. (2006) Low serum micronutrient concentrations predict frailty among older women living in the community. J Gerontol A Biol Sci Med Sci 61, 594-599.
83. Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM and Kivlahan DR. (2004) Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. J Am Geriatr Soc 52, 2077-2081.
84. Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P and Ross C. (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82, 1661-1667.
85. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF and Bhasin S. (2003) Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144, 5081-5088.
86. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML and Bhasin S. (2006) Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 91, 3024-3033.
87. Skelton DA, Greig CA, Davies JM and Young A. (1994) Strength, power and related functional ability of healthy people aged 65-89years. Age Ageing 23, 371-377.
88. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA et al. (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65years of age. J Clin Endocrinol Metab 84, 2647-2653.
89. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A et al. (2000) Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85, 2670-2677.
90. Srinivas-Shankar U and Wu F. (2006) Drug insight: testosterone preparations. Nat Clin Pract Urol 3, 653-665.
91. Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MDL, Adams JE, Oldham JA and Wu FCW. (2010) Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95, 639-650.
92. Storer TW, Magliano L, Woodhouse L, Lee ML, Dzekov C, Dzekov J, Casaburi R and Bhasin S. (2003) Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab 88, 1478-1485.
93. Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J and Bhasin S. (2008) Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc 56, 1991-1999.
94. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR and Kaplan GA. (1998) Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci 53, S9-S16.
95. Szulc P, Duboeuf F, Marchand F and Delmas PD. (2004) Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr 80, 496-503.
96. Tenover JS. (1992) Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75, 1092-1098.
97. Travison TG, Araujo AB, Kupelian V, O'Donnell AB and McKinlay JB. (2007) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92, 549-555.
98. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR and Ferrando A. (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol Endocrinol Metab 269, E820-E826.
99. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J and Fried LPfor the Cardiovascular Health Study I. (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162, 2333-2341.
100. Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler WB, Harris T and Fried LP. (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54, 991-1001.
101. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L and Swerdloff RS. (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89, 2085-2098.
102. Waters DL, Yau CL, Montoya GD and Baumgartner RN. (2003) Serum sex hormones, IGF-1, and IGFBP3 exert a sexually dimorphic effect on lean body mass in aging. J Gerontol A Biol Sci Med Sci 58, M648-M652.
103. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P and Morley JE. (2003) Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 58, M618-M625.
104. Wu FCW, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW et al. (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93, 2737-2745.